Caverject and Ejaculation failure - a phase IV clinical study of FDA data

Summary:

Ejaculation failure is reported as a side effect among people who take Caverject (alprostadil), especially for people who are 60+ old, also take Viagra, and have Diabetes.

The phase IV clinical study analyzes which people have Ejaculation failure when taking Caverject. It is created by eHealthMe based on reports of 2,123 people who have side effects when taking Caverject from the FDA, and is updated regularly.

What is Caverject?

Caverject has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,144 Caverject users. Check the latest studies of Caverject.

What is Ejaculation failure?

Ejaculation failure is found to be associated with 128 drugs and 382 conditions by eHealthMe. Check the latest studies of Ejaculation failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

2,123 people reported to have side effects when taking Caverject.
Among them, 14 people (0.66%) have Ejaculation failure.

Could Caverject cause Ejaculation failure?

Among these 14 people:

What is the age of people who have Ejaculation failure when taking Caverject? *

What are other drugs people take besides Caverject? *

What are other side effects people have besides Ejaculation failure? *

Erection Increased: 7 people, 50.00%
Drug Ineffective: 5 people, 35.71%
Accident: 4 people, 28.57%
Numbness And Tingling (unusual prickling sensations): 4 people, 28.57%
Cervical Vertebral Fracture: 4 people, 28.57%
Libido Decreased (loss of interest in sex): 4 people, 28.57%
Muscle Spasms (muscle contraction): 4 people, 28.57%
Penile Pain: 4 people, 28.57%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 4 people, 28.57%
Pain: 4 people, 28.57%

What are the existing conditions these people have? *

Diabetes: 6 people, 42.86%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 35.71%
High Blood Pressure: 2 people, 14.29%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.14%
Pain In Extremity: 1 person, 7.14%
Nerve Injury: 1 person, 7.14%
Limb Injury: 1 person, 7.14%
Joint Injury: 1 person, 7.14%
Depression: 1 person, 7.14%
Back Injury: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Caverject and have Ejaculation failure?

- Check whether Ejaculation failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Caverject:

Caverject (2,144 reports)

Browse all side effects of Caverject:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ejaculation failure:

Ejaculation failure (128 drugs)

Browse all the conditions that are associated with Ejaculation failure:

Ejaculation failure (382 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil (the active ingredients of Caverject) and Caverject (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.